Morris Schambelan, MD

Email Morris
(415) 206-3351

1001 Potrero Ave
San Francisco, CA 94110

Visit CTSI Profile
  • Professor, School of Medicine

Displaying 1 - 172 of 172

  1. Lee AP, Mulligan K, Schambelan M, Murphy EJ, Weiss EJ. Growth hormone receptor antagonism with pegvisomant in insulin resistant non-diabetic men: A phase II pilot study. F1000Res. 2017; 6:614. View on Pubmed
  2. Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, Herraiz LA, Tai VW, Bergeron N, Bersot TP, Rao MN, Schambelan M, Mulligan K. Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. J Clin Endocrinol Metab. 2015 Jun; 100(6):2434-42. View on Pubmed
  3. Rao MN, Neylan TC, Grunfeld C, Mulligan K, Schambelan M, Schwarz JM. Subchronic sleep restriction causes tissue-specific insulin resistance. J Clin Endocrinol Metab. 2015 Apr; 100(4):1664-71. View on Pubmed
  4. Khanijow K, Unemori P, Leslie KS, Mulligan K, Schambelan M, Maurer T. Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy. Dermatol Res Pract. 2013; 2013:941740. View on Pubmed
  5. Campos GM, Rabl C, Havel PJ, Rao M, Schwarz JM, Schambelan M, Mulligan K. Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery. Surg Obes Relat Dis. 2014 Jan-Feb; 10(1):1-8. View on Pubmed
  6. Park-Sigal J, Don BR, Porzig A, Recker R, Griswold V, Sebastian A, Duh QY, Portale AA, Shoback D, Schambelan M. Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone. J Bone Miner Res. 2013 Mar; 28(3):700-8. View on Pubmed
  7. Rao MN, Schambelan M, Tai VW, Abrams DI, Khatami H, Havel PJ, Sakkas G, Mulligan K. Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men. AIDS Res Treat. 2012; 2012:103072. View on Pubmed
  8. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von Haehling S, Yeh SS, Anker SD. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011 Jul; 12(6):403-9. View on Pubmed
  9. Winterstein AG, Heckbert SR, Schambelan M. Intensive glucose lowering and cardiovascular outcomes. N Engl J Med. 2011 06 09; 364(23):2263; author reply 2264. View on Pubmed
  10. Masharani UB, Maddux BA, Li X, Sakkas GK, Mulligan K, Schambelan M, Goldfine ID, Youngren JF. Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle. PLoS One. 2011 May 11; 6(5):e19878. View on Pubmed
  11. Weinberg ME, Roman MC, Jacob P, Wen M, Cheung P, Walker UA, Mulligan K, Schambelan M. Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement. PLoS One. 2011 Feb 17; 6(2):e14709. View on Pubmed
  12. Taylor SA, Lee GA, Pao VY, Anthonypillai J, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers. J Acquir Immune Defic Syndr. 2010 Nov; 55(3):361-4. View on Pubmed
  13. Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance. J Clin Endocrinol Metab. 2010 Sep; 95(9):4361-6. View on Pubmed
  14. Shrestha S, Irvin MR, Taylor KD, Wiener HW, Pajewski NM, Haritunians T, Delaney JA, Schambelan M, Polak JF, Arnett DK, Chen YD, Grunfeld C. A genome-wide association study of carotid atherosclerosis in HIV-infected men. AIDS. 2010 Feb 20; 24(4):583-92. View on Pubmed
  15. Pao VY, Lee GA, Taylor S, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers. AIDS. 2010 Jan 16; 24(2):265-70. View on Pubmed
  16. Sakkas GK, Schambelan M, Mulligan K. Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting? Curr Opin Clin Nutr Metab Care. 2009 Nov; 12(6):623-7. View on Pubmed
  17. Campos GM, Rabl C, Peeva S, Ciovica R, Rao M, Schwarz JM, Havel P, Schambelan M, Mulligan K. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg. 2010 Jan; 14(1):15-23. View on Pubmed
  18. Lee GA, Schwarz JM, Patzek S, Kim S, Dyachenko A, Wen M, Mulligan K, Schambelan M, Grunfeld C. The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):246-8. View on Pubmed
  19. Sakkas GK, Mulligan K, Dasilva M, Doyle JW, Khatami H, Schleich T, Kent-Braun JA, Schambelan M. Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study. PLoS One. 2009; 4(2):e4605. View on Pubmed
  20. Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai VW, Wen MJ, Lee GA, Grunfeld C, Schambelan M. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol Metab. 2009 Apr; 94(4):1137-44. View on Pubmed
  21. Schambelan M, Wilson PW, Yarasheski KE, Cade WT, Dávila-Román VG, D'Agostino RB, Helmy TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW. Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. Circulation. 2008 Jul 08; 118(2):e48-53. View on Pubmed
  22. Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH. State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation. 2008 Jul 08; 118(2):198-210. View on Pubmed
  23. Lee GA, Rao M, Mulligan K, Lo JC, Aweeka F, Schwarz JM, Schambelan M, Grunfeld C. Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers. AIDS. 2007 Oct 18; 21(16):2183-90. View on Pubmed
  24. Li X, Youngren JF, Hyun B, Sakkas GK, Mulligan K, Majumdar S, Masharani UB, Schambelan M, Goldfine ID. Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T. Magn Reson Imaging. 2008 Feb; 26(2):188-97. View on Pubmed
  25. Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Endocrinol Metab. 2007 Feb; 92(2):563-70. View on Pubmed
  26. Lee GA, Lo JC, Aweeka F, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers. Clin Infect Dis. 2006 Sep 01; 43(5):658-60. View on Pubmed
  27. Lo JC, Kazemi MR, Hsue PY, Martin JN, Deeks SG, Schambelan M, Mulligan K. The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection. Clin Infect Dis. 2005 Nov 01; 41(9):1335-40. View on Pubmed
  28. Schwarz JM, Lee GA, Park S, Noor MA, Lee J, Wen M, Lo JC, Mulligan K, Schambelan M, Grunfeld C. Indinavir increases glucose production in healthy HIV-negative men. AIDS. 2004 Sep 03; 18(13):1852-4. View on Pubmed
  29. Lo JC, Mulligan K, Noor MA, Lee GA, Schwarz JM, Grunfeld C, Schambelan M. The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study. Clin Infect Dis. 2004 Sep 01; 39(5):732-5. View on Pubmed
  30. Lee GA, Mafong DD, Noor MA, Lo JC, Mulligan K, Schwarz JM, Schambelan M, Grunfeld C. HIV protease inhibitors increase adiponectin levels in HIV-negative men. J Acquir Immune Defic Syndr. 2004 May 01; 36(1):645-7. View on Pubmed
  31. Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz JM, Aweeka FT, Mulligan K, Schambelan M, Grunfeld C. The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS. 2004 Mar 05; 18(4):641-9. View on Pubmed
  32. Zambon AC, McDearmon EL, Salomonis N, Vranizan KM, Johansen KL, Adey D, Takahashi JS, Schambelan M, Conklin BR. Time- and exercise-dependent gene regulation in human skeletal muscle. Genome Biol. 2003; 4(10):R61. View on Pubmed
  33. Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003 Aug 19; 139(4):258-66. View on Pubmed
  34. Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002 Nov 01; 31(3):257-75. View on Pubmed
  35. Tai VW, Schambelan M, Algren H, Shayevich C, Mulligan K. Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting. Clin Infect Dis. 2002 Nov 15; 35(10):1258-62. View on Pubmed
  36. Mulligan K, Schambelan M. Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. Int J Cardiol. 2002 Sep; 85(1):151-9. View on Pubmed
  37. Napolitano LA, Lo JC, Gotway MB, Mulligan K, Barbour JD, Schmidt D, Grant RM, Halvorsen RA, Schambelan M, McCune JM. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS. 2002 May 24; 16(8):1103-11. View on Pubmed
  38. Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS. 2002 Mar 29; 16(5):F1-8. View on Pubmed
  39. Schwarz JM, Mulligan K, Lee J, Lo JC, Wen M, Noor MA, Grunfeld C, Schambelan M. Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab. 2002 Feb; 87(2):942. View on Pubmed
  40. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994 Nov 04; 79(3):407-14. View on Pubmed
  41. Lim RC, Nakayama DK, Biglieri EG, Schambelan M, Hunt TK. Primary aldosteronism: changing concepts in diagnosis and management. Am J Surg. 1986 Jul; 152(1):116-21. View on Pubmed
  42. Biglieri EG, Schambelan M. Endocrine hypertension. Clin Endocrinol Metab. 1981 Nov; 10(3):ix-xi. View on Pubmed
  43. Korobkin M, Glickman MG, Schambelan M. Segmental renal vein sampling for renin. Radiology. 1976 Feb; 118(2):307-13. View on Pubmed
  44. Clark OH, Hall AD, Schambelan M. Clinical manifestations of adrenal hemorrhage. Am J Surg. 1974 Aug; 128(2):219-24. View on Pubmed
  45. Golde DW, Schambelan M, Weintraub BD, Rosen SW. Gonadotropin-secreting renal carcinoma. Cancer. 1974 Apr; 33(4):1048-53. View on Pubmed
  46. Eichner HL, Schambelan M, Biglieri EG. Systemic lupus erythematosus with adrenal insufficiency. Am J Med. 1973 Nov; 55(5):700-5. View on Pubmed
  47. Schambelan M, Slaton PE, Murray JF, Biglieri EG. Adrenal insufficiency and inappropriate secretion of antidiuretic hormone. Occurrence in a patient with carcinoma of the lung. Arch Intern Med. 1969 Aug; 124(2):197-201. View on Pubmed
  48. Schambelan M, Sussman S. Encephalitis and purpura with influenza infection. A case report. Am J Dis Child. 1966 Mar; 111(3):302-3. View on Pubmed
  49. Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA. 1999 Apr 14; 281(14):1275-81. View on Pubmed
  50. Westphal CH, Muller L, Zhou A, Zhu X, Bonner-Weir S, Schambelan M, Steiner DF, Lindberg I, Leder P. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell. 1999 Mar 05; 96(5):689-700. View on Pubmed
  51. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. Body shape changes in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 01; 19(3):307-8. View on Pubmed
  52. Engler MM, Schambelan M, Engler MB, Ball DL, Goodfriend TL. Effects of dietary gamma-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proc Soc Exp Biol Med. 1998 Jul; 218(3):234-7. View on Pubmed
  53. Johansen KL, Mulligan K, Tai V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol. 1998 Jun; 9(6):1080-4. View on Pubmed
  54. Mulligan K, Tai VW, Schambelan M. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study. J Clin Endocrinol Metab. 1998 May; 83(5):1542-7. View on Pubmed
  55. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet. 1998 Mar 21; 351(9106):867-70. View on Pubmed
  56. Sechi LA, Griffin CA, Zingaro L, Catena C, De Carli S, Schambelan M, Bartoli E. Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats. Am J Hypertens. 1997 Nov; 10(11):1223-30. View on Pubmed
  57. Deeks SG, Coleman RL, White R, Pachl C, Schambelan M, Chernoff DN, Feinberg MB. Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. J Infect Dis. 1997 Aug; 176(2):514-7. View on Pubmed
  58. Sechi LA, Griffin CA, Zingaro L, Valentin JP, Bartoli E, Schambelan M. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats. Diabetologia. 1997 Jul; 40(7):770-7. View on Pubmed
  59. Mulligan K, Tai VW, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 01; 15(1):43-8. View on Pubmed
  60. Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M. The renin-angiotensin system and compensatory renal hypertrophy in the rat. Am J Hypertens. 1997 Apr; 10(4 Pt 1):397-402. View on Pubmed
  61. Mulligan K, Tai VW, Schambelan M. Energy expenditure in human immunodeficiency virus infection. N Engl J Med. 1997 Jan 02; 336(1):70-1. View on Pubmed
  62. Griffin CA, Giacchetti G, Schambelan M, Sechi LA. Ontogenic expression of renal and hepatic angiotensin II receptor genes in the rat. Nephron. 1997; 76(1):103-10. View on Pubmed
  63. Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E. Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia. 1997 Jan; 40(1):23-9. View on Pubmed
  64. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med. 1996 Dec 01; 125(11):873-82. View on Pubmed
  65. Meiner VL, Cases S, Myers HM, Sande ER, Bellosta S, Schambelan M, Pitas RE, McGuire J, Herz J, Farese RV. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci U S A. 1996 Nov 26; 93(24):14041-6. View on Pubmed
  66. Sechi LA, Griffin CA, Giacchetti G, Valentin JP, Llorens-Cortes C, Corvol P, Schambelan M. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension. 1996 Sep; 28(3):403-8. View on Pubmed
  67. Benowitz NL, Zevin S, Carlsen S, Wright J, Schambelan M, Cheitlin M. Orthostatic hypertension due to vascular adrenergic hypersensitivity. Hypertension. 1996 Jul; 28(1):42-6. View on Pubmed
  68. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med. 1996 Apr 15; 124(8):708-16. View on Pubmed
  69. Sechi LA, Griffin CA, Giacchetti G, Zingaro L, Catena C, Bartoli E, Schambelan M. Abnormalities of insulin receptors in spontaneously hypertensive rats. Hypertension. 1996 Apr; 27(4):955-61. View on Pubmed
  70. Jeunemaitre X, Charru A, Pascoe L, Guyene TT, Aupetit-Faisant B, Shackleton CH, Schambelan M, Plouin PF, Corvol P. [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study]. Presse Med. 1995 Sep 23; 24(27):1243-8. View on Pubmed
  71. Sechi LA, Valentin JP, Griffin CA, Lee E, Bartoli E, Humphreys MH, Schambelan M. Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus. J Clin Invest. 1995 Jun; 95(6):2451-7. View on Pubmed
  72. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994 Nov 04; 79(3):407-14. View on Pubmed
  73. Sechi LA, Griffin CA, Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes. 1994 Oct; 43(10):1180-4. View on Pubmed
  74. Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M. [Gene expression of the renin-angiotensin system in compensatory renal hypertrophy secondary to contralateral nephrectomy]. Arch Mal Coeur Vaiss. 1994 Aug; 87(8):1115-7. View on Pubmed
  75. Schambelan M. Licorice ingestion and blood pressure regulating hormones. Steroids. 1994 Feb; 59(2):127-30. View on Pubmed
  76. Sechi LA, Griffin CA, Schambelan M. Effect of dietary sodium chloride on insulin receptor number and mRNA levels in rat kidney. Am J Physiol. 1994 Jan; 266(1 Pt 2):F31-8. View on Pubmed
  77. Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M. Renin-angiotensin system gene expression during compensatory renal hypertrophy in the rat. J Hypertens Suppl. 1993 Dec; 11(5):S236-7. View on Pubmed
  78. Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, Kraemer FB, Hoffman AR, Schambelan M. The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. J Am Soc Nephrol. 1993 Dec; 4(6):1337-45. View on Pubmed
  79. Sechi LA, Griffin CA, De Carli S, Sechi G, Schambelan M, Bartoli E. [Angiotensin II receptors in the heart conduction tissue]. Minerva Cardioangiol. 1993 Nov; 41(11):511-6. View on Pubmed
  80. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab. 1993 Oct; 77(4):956-62. View on Pubmed
  81. Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors]. Cardiologia. 1993 Aug; 38(8):519-23. View on Pubmed
  82. Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E. [Angiotensin receptors in the rat myocardium during pre- and postnatal development]. Cardiologia. 1993 Jul; 38(7):471-6. View on Pubmed
  83. Sechi LA, Valentin JP, Griffin CA, Schambelan M. Autoradiographic characterization of angiotensin II receptor subtypes in rat intestine. Am J Physiol. 1993 Jul; 265(1 Pt 1):G21-7. View on Pubmed
  84. Valentin JP, Sechi LA, Qui C, Schambelan M, Humphreys MH. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension. 1993 Apr; 21(4):432-8. View on Pubmed
  85. Masharani U, Schambelan M. The endocrine complications of acquired immunodeficiency syndrome. Adv Intern Med. 1993; 38:323-36. View on Pubmed
  86. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res. 1992 Dec; 71(6):1482-9. View on Pubmed
  87. Ray PE, Schambelan M, Hintz R, Ruley EJ, Harrah J, Holliday MA. Plasma renin activity as a marker for growth failure due to sodium deficiency in young rats. Pediatr Nephrol. 1992 Nov; 6(6):523-6. View on Pubmed
  88. Sechi LA, Griffin CA, Grady EF, Grunfeld C, Kalinyak JE, Schambelan M. Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes. 1992 Sep; 41(9):1113-8. View on Pubmed
  89. al-Uzri A, Holliday MA, Gambertoglio JG, Schambelan M, Kogan BA, Don BR. An accurate practical method for estimating GFR in clinical studies using a constant subcutaneous infusion. Kidney Int. 1992 Jun; 41(6):1701-6. View on Pubmed
  90. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am J Physiol. 1992 Feb; 262(2 Pt 2):F236-40. View on Pubmed
  91. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177. J Hypertens Suppl. 1991 Dec; 9(6):S224-5. View on Pubmed
  92. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Insulin receptor concentration and gene expression are modulated by sodium intake in the rat kidney. J Hypertens Suppl. 1991 Dec; 9(6):S212-3. View on Pubmed
  93. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991 Sep; 88(3):921-33. View on Pubmed
  94. Wada L, Don BR, Schambelan M. Hormonal mediators of amino acid-induced glomerular hyperfiltration in humans. Am J Physiol. 1991 Jun; 260(6 Pt 2):F787-92. View on Pubmed
  95. Don BR, Kaysen GA, Hutchison FN, Schambelan M. The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria. Am J Kidney Dis. 1991 Jan; 17(1):10-7. View on Pubmed
  96. Kaysen GA, Don B, Schambelan M. Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome. Nephrol Dial Transplant. 1991; 6(2):141-9. View on Pubmed
  97. Don BR, Schambelan M. Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism. Kidney Int. 1990 Dec; 38(6):1159-63. View on Pubmed
  98. Anderson PW, Do YS, Schambelan M, Horton R, Boger RS, Luther RR, Hsueh WA. Effects of renin inhibition in systemic hypertension. Am J Cardiol. 1990 Dec 01; 66(19):1342-7. View on Pubmed
  99. Farese RV, Schambelan M, Hollander H, Stringari S, Jacobson MA. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis. Ann Intern Med. 1990 Jun 15; 112(12):955-6. View on Pubmed
  100. Don BR, Sebastian A, Cheitlin M, Christiansen M, Schambelan M. Pseudohyperkalemia caused by fist clenching during phlebotomy. N Engl J Med. 1990 May 03; 322(18):1290-2. View on Pubmed
  101. Denolle T, Rohmer V, Saint-Adnré JP, Guyene TT, Galland F, Bigorgne JC, Schambelan M, Corvol P. Effect of the circulating renin-angiotensin system on prolactin release in humans. J Clin Endocrinol Metab. 1990 Jan; 70(1):288-92. View on Pubmed
  102. Don BR, Wada L, Kaysen GA, Schambelan M. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome. Kidney Int Suppl. 1989 Nov; 27:S163-7. View on Pubmed
  103. Noth RH, Krolewski AS, Kaysen GA, Meyer TW, Schambelan M. Diabetic nephropathy: hemodynamic basis and implications for disease management. Ann Intern Med. 1989 May 15; 110(10):795-813. View on Pubmed
  104. Don BR, Blake S, Hutchison FN, Kaysen GA, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in the rat. Am J Physiol. 1989 Apr; 256(4 Pt 2):F711-8. View on Pubmed
  105. Toffelmire EB, Slater K, Corvol P, Menard J, Schambelan M. Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay. J Clin Invest. 1989 Feb; 83(2):679-87. View on Pubmed
  106. Schambelan M, Don BR, Kaysen GA, Blake S. Abnormalities of glomerular eicosanoid metabolism in states of glomerular hyperfiltration. Adv Exp Med Biol. 1989; 259:275-304. View on Pubmed
  107. Hutchinson FN, Schambelan M, Kaysen GA. Modulation of albuminuria by dietary protein and converting enzyme inhibition. Am J Physiol. 1987 Oct; 253(4 Pt 2):F719-25. View on Pubmed
  108. Don BR, Schambelan M. Diabetes, dietary protein and glomerular hyperfiltration. West J Med. 1987 Oct; 147(4):449-55. View on Pubmed
  109. Sebastian A, Schambelan M. Renal hyperkalemia. Semin Nephrol. 1987 Sep; 7(3):223-38. View on Pubmed
  110. Hernandez RE, Schambelan M, Cogan MG, Colman J, Morris RC, Sebastian A. Dietary NaCl determines severity of potassium depletion-induced metabolic alkalosis. Kidney Int. 1987 Jun; 31(6):1356-67. View on Pubmed
  111. Schambelan M, Sebastian A, Katuna BA, Arteaga E. Adrenocortical hormone secretory response to chronic NH4Cl-induced metabolic acidosis. Am J Physiol. 1987 Apr; 252(4 Pt 1):E454-60. View on Pubmed
  112. Hutchison FN, Don BR, Kaysen GA, Blake S, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in nephrotic rats. Adv Prostaglandin Thromboxane Leukot Res. 1987; 17B:725-8. View on Pubmed
  113. Lim RC, Nakayama DK, Biglieri EG, Schambelan M, Hunt TK. Primary aldosteronism: changing concepts in diagnosis and management. Am J Surg. 1986 Jul; 152(1):116-21. View on Pubmed
  114. Schambelan M, Blake S, Sraer J, Bens M, Nivez MP, Wahbe F. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest. 1985 Feb; 75(2):404-12. View on Pubmed
  115. Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production. J Clin Endocrinol Metab. 1985 Feb; 60(2):225-8. View on Pubmed
  116. Schambelan M, Sebastian A. [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia]. Nephrologie. 1985; 6(3):135-7. View on Pubmed
  117. Arteaga E, Biglieri EG, Kater CE, Lopez JM, Schambelan M. Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases. Ann Intern Med. 1984 Sep; 101(3):316-21. View on Pubmed
  118. Maher T, Schambelan M, Kurtz I, Hulter HN, Jones JW, Sebastian A. Amelioration of metabolic acidosis by dietary potassium restriction in hyperkalemic patients with chronic renal insufficiency. J Lab Clin Med. 1984 Mar; 103(3):432-45. View on Pubmed
  119. Sebastian A, Schambelan M, Sutton JM. Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis. Am J Nephrol. 1984; 4(5):287-300. View on Pubmed
  120. Williams FA, Schambelan M, Biglieri EG, Carey RM. Acquired primary hypoaldosteronism due to an isolated zona glomerulosa defect. N Engl J Med. 1983 Dec 29; 309(26):1623-7. View on Pubmed
  121. Ardaillou N, Nivez MP, Schambelan M, Ardaillou R. Response of adenylate cyclase to parathyroid hormone and prostaglandins by human isolated glomeruli. J Clin Endocrinol Metab. 1983 Dec; 57(6):1207-15. View on Pubmed
  122. Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A. Effect of diet on plasma acid-base composition in normal humans. Kidney Int. 1983 Nov; 24(5):670-80. View on Pubmed
  123. Kater CE, Biglieri EG, Schambelan M, Arteaga E. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism. Hypertension. 1983 Nov-Dec; 5(6 Pt 3):V115-21. View on Pubmed
  124. Landefeld CS, Schambelan M, Kaplan SL, Embury SH. Clomiphene-responsive hypogonadism in sickle cell anemia. Ann Intern Med. 1983 Oct; 99(4):480-3. View on Pubmed
  125. Kirby BD, Ham J, Fairley HB, Benowitz N, Schambelan M. Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations. West J Med. 1983 Aug; 139(2):221-5. View on Pubmed
  126. Sebastian A, Hulter HN, Kurtz I, Maher T, Schambelan M. Disorders of distal nephron function. Am J Med. 1982 Feb; 72(2):289-307. View on Pubmed
  127. Jones JW, Sebastian A, Hulter HN, Schambelan M, Sutton JM, Biglieri EG. Systemic and renal acid-base effects of chronic dietary potassium depletion in humans. Kidney Int. 1982 Feb; 21(2):402-10. View on Pubmed
  128. Perloff D, Schambelan M. Renovascular hypertension. Clin Endocrinol Metab. 1981 Nov; 10(3):513-35. View on Pubmed
  129. Biglieri EG, Schambelan M. Endocrine hypertension. Clin Endocrinol Metab. 1981 Nov; 10(3):ix-xi. View on Pubmed
  130. Humphreys MH, Al-Bander H, Eneas JF, Schambelan M. Factors determining electrolyte excretion and renin secretion after closure of an arteriovenous fistula in the dog. J Lab Clin Med. 1981 Jul; 98(1):89-98. View on Pubmed
  131. Schambelan M, Sebastian A, Rector FC. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Kidney Int. 1981 May; 19(5):716-27. View on Pubmed
  132. White RH, Schambelan M. Hypertension and angiographic findings in necrotizing vasculitis. Ann Intern Med. 1981 Mar; 94(3):410-1. View on Pubmed
  133. Rodriguez JA, Biglieri EG, Schambelan M. Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones. Trans Assoc Am Physicians. 1981; 94:172-82. View on Pubmed
  134. White EA, Schambelan M, Rost CR, Biglieri EG, Moss AA, Korobkin M. Use of computed tomography in diagnosing the cause of primary aldosteronism. N Engl J Med. 1980 Dec 25; 303(26):1503-7. View on Pubmed
  135. Sebastian A, Sutton JM, Hulter HN, Schambelan M, Poler SM. Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients. Kidney Int. 1980 Dec; 18(6):762-73. View on Pubmed
  136. Benowitz NL, Byrd R, Schambelan M, Rosenberg J, Roizen MF. Dihydroergotamine treatment for orthostatic hypotension from Vacor rodenticide. Ann Intern Med. 1980 Mar; 92(3):387-8. View on Pubmed
  137. Hulter HN, Sebastian A, Sigala JF, Licht JH, Glynn RD, Schambelan M, Biglieri EG. Pathogenesis of renal hyperchloremic acidosis resulting from dietary potassium restriction in the dog: role of aldosterone. Am J Physiol. 1980 Feb; 238(2):F79-91. View on Pubmed
  138. White RH, Schambelan M. Hypertension, hyperreninemia, and secondary hyperaldosteronism in systemic necrotizing vasculitis. Ann Intern Med. 1980 Feb; 92(2 Pt 1):199-201. View on Pubmed
  139. Schambelan M, Sebastian A, Biglieri EG. Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency. Kidney Int. 1980 Jan; 17(1):89-101. View on Pubmed
  140. Biglieri EG, Brust N, Chang B, Hirai J, Wajchenberg BL, Schambelan M. Clinical manifestation of adrenocorticotropin-determined plasma concentrations of mineralocorticoid hormones. Prog Biochem Pharmacol. 1980; 17:36-43. View on Pubmed
  141. Biglieri EG, Chang B, Hirai J, Brust N, Rost CR, Schambelan M. Adrenocorticotropin inhibition of mineralocorticoid hormone production. Clin Sci (Lond). 1979 Dec; 57 Suppl 5:307s-311s. View on Pubmed
  142. Biglieri EG, Schambelan M. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. J Clin Endocrinol Metab. 1979 Jul; 49(1):87-91. View on Pubmed
  143. Schambelan M, Sebastian A. Hyporeninemic hypoaldosteronism. Adv Intern Med. 1979; 24:385-405. View on Pubmed
  144. Sebastian A, Schambelan M, Lindenfeld S, Morris RC. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. N Engl J Med. 1977 Sep 15; 297(11):576-83. View on Pubmed
  145. Hogan MJ, Schambelan M, Biglieri EG. Concurrent hypercortisolism and hypermineralocorticoidism. Am J Med. 1977 May; 62(5):777-82. View on Pubmed
  146. Potter DE, Schambelan M, Salvatierra O, Orloff S, Holliday MA. Treatment of high-renin hypertension with propranolol in children after renal transplantation. J Pediatr. 1977 Feb; 90(2):307-11. View on Pubmed
  147. Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Bartter FC. Role of steroids in hypertension: evaluation of plasma mineralocorticoid activity with aldosterone receptors. Clin Sci Mol Med Suppl. 1976 Dec; 3:321s-324s. View on Pubmed
  148. Matulich DT, Spindler BJ, Schambelan M, Baxter JD. Mineralocorticoid receptors in human kidney. J Clin Endocrinol Metab. 1976 Nov; 43(5):1170-4. View on Pubmed
  149. Kershnar AK, Borut D, Kogut MD, Biglieri EG, Schambelan M. Studies in a phenotypic female with 17-alpha-hydroxylase deficiency. J Pediatr. 1976 Sep; 89(3):395-400. View on Pubmed
  150. Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Taylor AA, Bartter FC. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states. J Clin Invest. 1976 Sep; 58(3):579-89. View on Pubmed
  151. Schambelan M, Brust NL, Chang BC, Slater KL, Biglieri EG. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab. 1976 Jul; 43(1):115-31. View on Pubmed
  152. Hogan MJ, McRae J, Schambelan M, Biglieri EG. Location of aldosterone-producing adenomas with 131I-19-iodocholesterol. N Engl J Med. 1976 Feb 19; 294(8):410-4. View on Pubmed
  153. Korobkin M, Glickman MG, Schambelan M. Segmental renal vein sampling for renin. Radiology. 1976 Feb; 118(2):307-13. View on Pubmed
  154. Hunt TK, Schambelan M, Biglieri EG. Selection of patients and operative approach in primary aldosteronism. Ann Surg. 1975 Oct; 182(4):353-61. View on Pubmed
  155. Schambelan M. Letter: Hyporeninemic hypoaldosteronism in chronic renal disease. Metabolism. 1975 Jun; 24(6):793-4. View on Pubmed
  156. Clark OH, Hall AD, Schambelan M. Clinical manifestations of adrenal hemorrhage. Am J Surg. 1974 Aug; 128(2):219-24. View on Pubmed
  157. Schambelan M, Glickman M, Stockigt JR, Biglieri EG. Selective renal-vein renin sampling in hypertensive patients with segmental renal lesions. N Engl J Med. 1974 May 23; 290(21):1153-7. View on Pubmed
  158. Golde DW, Schambelan M, Weintraub BD, Rosen SW. Gonadotropin-secreting renal carcinoma. Cancer. 1974 Apr; 33(4):1048-53. View on Pubmed
  159. Eichner HL, Schambelan M, Biglieri EG. Systemic lupus erythematosus with adrenal insufficiency. Am J Med. 1973 Nov; 55(5):700-5. View on Pubmed
  160. Schambelan M, Howes EL, Noakes CA, Biglieri EG. Role of renin and aldosterone in hypertension due to a renin-secreting tumor. Am J Med. 1973 Jul; 55(1):86-92. View on Pubmed
  161. Stockigt JR, Hertz P, Schambelan M, Biglieri EG. Segmental renal-vein renin sampling for segmental renal infarction. Studies in a hypertensive patient. Ann Intern Med. 1973 Jul; 79(1):67-70. View on Pubmed
  162. Schambelan M, Stockigt JR, Biglieri EG. Isolated hypoaldosteronism in adults. A renin-deficiency syndrome. N Engl J Med. 1972 Sep 21; 287(12):573-8. View on Pubmed
  163. Stockigt JR, Collins RD, Noakes CA, Schambelan M, Biglieri EG. Renal-vein renin in various forms of renal hypertension. Lancet. 1972 Jun 03; 1(7762):1194-7. View on Pubmed
  164. Biglieri EG, Stockigt JR, Schambelan M. Adrenal mineralocorticoids causing hypertension. Am J Med. 1972 May; 52(5):623-32. View on Pubmed
  165. Schambelan M, Biglieri EG. Deoxycorticosterone production and regulation in man. J Clin Endocrinol Metab. 1972 Apr; 34(4):695-703. View on Pubmed
  166. Schambelan M, Slaton PE, Biglieri EG. Mineralocorticoid production in hyperadrenocorticism. Role in pathogenesis of hypokalemic alkalosis. Am J Med. 1971 Sep; 51(3):299-303. View on Pubmed
  167. Biglieri EG, Stockigt JR, Schambelan M. A preliminary evaluation for primary aldosteronism. Arch Intern Med. 1970 Dec; 126(6):1004-7. View on Pubmed
  168. Biglieri EG, Schambelan M, Slaton PE, Stockigt JR. The intercurrent hypertension of primary aldosteronism. Circ Res. 1970 Jul; 27(1 Suppl 1):195-202. View on Pubmed
  169. Schambelan M, Slaton PE, Murray JF, Biglieri EG. Adrenal insufficiency and inappropriate secretion of antidiuretic hormone. Occurrence in a patient with carcinoma of the lung. Arch Intern Med. 1969 Aug; 124(2):197-201. View on Pubmed
  170. Slaton PE, Schambelan M, Biglieri EG. Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma. J Clin Endocrinol Metab. 1969 Feb; 29(2):239-50. View on Pubmed
  171. Biglieri EG, Slaton PE, Schambelan M, Kronfield SJ. Hypermineralocorticoidism. Am J Med. 1968 Aug; 45(2):170-5. View on Pubmed
  172. Schambelan M, Sussman S. Encephalitis and purpura with influenza infection. A case report. Am J Dis Child. 1966 Mar; 111(3):302-3. View on Pubmed